FLG and Alzheimer disease: These results are corroborated by similar relative compositions and amounts of SC ceramides—a profile which directly correlates with epidermal barrier efficacy [171,172,173]—in non-lesional skin of FLG-mutated and FLG wild-type AD patients [162,167].